Skip to main content
. 2019 Apr 2;27(5):492–501. doi: 10.4062/biomolther.2018.199

Fig. 1.

Fig. 1.

Chemical structures. (A) Heterocyclic isoquinoline, quinazolinones and indole backbones. (B) FDA-approved kinase inhibitors with quinoline (Gefitinib), quinazinolone (Idelalisib) or indole (Midostaurin) scaffolds.